• Marein Restores Chemosensitivity to Mitoxantrone via ABCG2 I

  2026-07-26

  This study demonstrates that marein, a flavonoid from Coreopsis tinctoria, acts as a competitive inhibitor of the ABCG2 transporter. By blocking ABCG2-mediated drug efflux, marein restores chemosensitivity to anticancer agents such as mitoxantrone, highlighting a promising strategy for overcoming multidrug resistance in cancer research.

• Nilotinib (AMN-107): Data-Driven Reliability in CML Research

  2026-07-25

  This article explores real-world laboratory scenarios where Nilotinib (AMN-107, SKU A8232) from APExBIO addresses common challenges in kinase inhibitor experiments. Through evidence-backed Q&A, we demonstrate how A8232 enhances reproducibility and assay sensitivity in chronic myeloid leukemia and kinase-driven tumor research.

• Fluorescein TSA Fluorescence System Kit: Transforming Endoth

  2026-07-24

  Explore how the Fluorescein TSA Fluorescence System Kit enables ultrasensitive detection of low-abundance biomolecules, with scientific depth on endothelial-centric mechanisms and practical insights for advanced IHC, ICC, and ISH workflows.

• METTL17 Modulates Ferroptosis and Tumorigenesis in Colorecta

  2026-07-24

  This study uncovers METTL17 as a mitochondrial regulator of ferroptosis resistance and tumorigenesis in colorectal cancer, primarily by modulating mitochondrial RNA methylation and translation. The findings reveal a new therapeutic axis for overcoming ferroptosis resistance in CRC, with implications for targeted combination treatments.

• TRPV1+ Nerve Stimulation Modulates Systemic Inflammation via

  2026-07-23

  Song et al. (2025) uncover that targeted stimulation of TRPV1+ peripheral somatosensory nerves at the nape initiates a somato-autonomic reflex, rapidly suppressing systemic inflammation. This mechanistic insight clarifies neuro-immune crosstalk and suggests novel, non-pharmacological approaches to immune modulation.

• ALOX5 Deficiency Drives Ferroptosis Escape in Bladder Cancer

  2026-07-23

  This study uncovers how ALOX5 loss confers resistance to ferroptosis in bladder cancer, facilitating tumor progression. By elucidating the transcriptional regulation of ALOX5 and its clinical relevance, the work highlights new prognostic and therapeutic targets for advanced bladder cancer.

• Kv1.3 Blockade Redefined: Mechanistic and Strategic Frontier

  2026-07-22

  Explore how Psora 4, a highly selective Kv1.3 blocker from APExBIO, is reshaping immunomodulatory research by integrating advanced insights into T cell calcium signaling, effector memory T cell inhibition, and the nuanced role of channel subunits like KCNE4. This article bridges mechanistic breakthroughs with actionable strategies for translational researchers, outlining protocol parameters and the evolving landscape of Kv1.3-targeted immunomodulation in autoimmunity models.

• Fluo-4 AM Calcium Assay Kit: Decoding Scaffold Fiber Density

  2026-07-22

  Explore how the Fluo-4 AM Calcium Assay Kit enables unprecedented insight into fiber density–driven mechanotransduction in tissue engineering. This article delivers advanced analysis of calcium dynamics in live cells, with actionable guidance for innovative scaffold design.

• Iron-Dependent KDM4D Regulates MSC Fate via PI3K-Akt-Foxo1 A

  2026-07-21

  This study demonstrates that iron-dependent activity of the histone demethylase KDM4D governs the balance between quiescence and activation of mesenchymal stem cells (MSCs) through the PI3K-Akt-Foxo1 signaling pathway. The findings establish a mechanistic link between iron deficiency, impaired MSC mobilization, and bone loss, with significant implications for metabolic bone disease research.

• HPF: Advancing Precision hROS Detection for Translational On

  2026-07-21

  Explore the mechanistic role, validation strategies, and translational impact of HPF (hydroxyphenyl fluorescein) as a next-generation probe for highly reactive oxygen species (hROS) in cancer therapy research. This article bridges molecular insight with strategic guidance for cell biologists, highlighting HPF’s pivotal role in multimodal ROS-driven theranostics, with contextual reference to emerging nanodynamic therapies and workflow optimization.

• Reliable Real-Time PCR with HotStart™ 2X Green qPCR Master M

  2026-07-20

  This article provides scenario-driven guidance for biomedical researchers and technicians facing challenges in cell-based qPCR workflows. By examining evidence and real lab situations, it demonstrates how HotStart™ 2X Green qPCR Master Mix (SKU K1070) from APExBIO delivers reproducibility and precision for gene expression, nucleic acid quantification, and RNA-seq validation.

• High-Throughput Blood-Brain Barrier Model: Predictive Advanc

  2026-07-20

  This study establishes a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating lysosomal trapping correction for enhanced prediction of CNS drug permeability. The approach demonstrates robust in vitro-in vivo correlation, offering a reliable, scalable platform for early-stage central nervous system (CNS) drug screening.

• Olaparib (AZD2281): Applied Protocols in DNA Damage Response

  2026-07-19

  Olaparib (AZD2281) from APExBIO empowers researchers to dissect DNA repair mechanisms with rigor and flexibility, especially in BRCA-deficient cancer models. This article distills cutting-edge workflows, troubleshooting tips, and new synergy insights for DNA damage response and tumor radiosensitization studies.

• 6-Thioguanine Suppresses EV71 via BIRC3-Mediated Autophagy I

  2026-07-18

  This study demonstrates that 6-thioguanine significantly inhibits EV71 replication by targeting BIRC3-mediated autophagy pathways in vitro. The findings provide mechanistic insight and a strong rationale for further preclinical evaluation of thioguanine as a candidate therapy for severe hand, foot, and mouth disease.

• Imatinib (STI571) in Next-Gen Kinase Assays: Precision, Limi

  2026-07-17

  Explore how Imatinib (STI571) enables advanced kinase inhibition assays and signal transduction research. This article uniquely connects cutting-edge mass spectrometry imaging innovations to practical protocol optimization for cancer biology and kinase pathway studies.

450 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page